UPC CFI, LD Munich, 17 January 2025: Replacements after corporate restructuring Sanofi
20-02-2025 Print this page
Sanofi Mature IP replaced by Sanofi SA in the present and all related proceedings (without objection) (R. 305 RoP).
On 29 September 2024, the Sanofi group reorganized its group of companies, and Sanofi Mature IP has been dissolved without liquidation as all the shares of Sanofi Mature IP came to be held by its single shareholder, Sanofi SA. This resulted in the universal transfer of assets of Sanofi Mature IP to Sanofi SA, including the ownership of EP 466.
IPPT20250117, UPC CFI, LD Munich, Sanofi v Accord
Change in parties (R. 305 RoP, R. 306 RoP, R. 310 RoP). Sanofi-Aventis France, which ceased to exist, is replaced by Sanofi Winthrop Industrie.
As Sanofi Winthrop Industrie is already party to the proceedings this replacement has no consequence on proceedings. Sanofi Winthrop Industrie is bound by the proceedings as now constituted.
Since it is undisputed that Sanofi Winthrop Industrie succeeded Sanofi-Aventis France from the moment Sanofi-Aventis France ceased to exist, there is no need to order a formal stay. It is sufficient to order that Sanofi-Aventis France be replaced by Sanofi-Aventis France.
Since this decision may be reversed, Claimant No 2 shall be designated "Sanofi Winthrop Industrie as successor to Sanofi-Aventis France" in addition to Claimant No 2, which remains "Sanofi Winthrop Industrie".
